HCG 10,000iu Canada

Technical Specifications

Compound Name: Human Chorionic Gonadotropin (hCG)
Quantity: 10,000 international units (IU) per vial
Format: Lyophilized powder
Molecular Type: Glycoprotein hormone
Subunit Structure: Alpha and beta subunits
Research Classification: Investigational hormone – laboratory research use only

HCG 10,000 IU (Canada) is supplied as a lyophilized glycoprotein hormone intended exclusively for laboratory and analytical applications. Each vial contains 10,000 international units of purified human chorionic gonadotropin prepared under controlled handling and quality verification standards appropriate for research material distribution.

This product is classified as an investigational research compound and is not authorized for therapeutic, diagnostic, or consumer use in Canada when supplied in research format.

Research Overview

Human chorionic gonadotropin (hCG) is a naturally occurring glycoprotein hormone produced during pregnancy. It plays a central role in reproductive endocrinology and has been widely studied in both clinical and laboratory research contexts.

HCG 10,000 IU Canada, when supplied for research purposes, is used in laboratory settings to examine luteinizing hormone (LH) receptor signalling, gonadal steroidogenesis pathways, and endocrine regulation models. Due to structural similarities between hCG and LH, hCG has been utilized extensively in research on receptor activation mechanisms in reproductive biology.

In the academic literature, hCG is cited in studies on hormone signalling cascades, cyclic AMP pathway activation, and gonadal cell responses under controlled experimental conditions. Research applications may include cell culture assays, receptor-binding studies, and animal-model investigations.

HCG 10,000 IU, provided in research-grade form, is intended strictly for laboratory study. Any references to physiological pathways reflect established endocrinology research and do not imply consumer or therapeutic use of this research product.

Mechanism Overview

hCG is composed of two subunits: an alpha subunit shared with other glycoprotein hormones (such as LH, FSH, and TSH) and a unique beta subunit that confers receptor specificity.

In laboratory models, hCG binds to the luteinizing hormone/choriogonadotropin receptor (LHCGR), which is expressed in gonadal tissues. Receptor activation stimulates adenylate cyclase activity, increasing intracellular cyclic AMP (cAMP) levels and activating downstream signalling pathways.

These signalling cascades influence steroidogenic enzyme expression and hormone synthesis in experimental systems. HCG 10,000iu Canada is often studied in vitro to evaluate receptor sensitivity, signal transduction dynamics, and hormone–receptor interaction kinetics.

Mechanistic descriptions remain confined to established endocrine research and do not represent instructions or guidance for human administration.

Clinical Development Context

hCG has a long history of regulated clinical use in authorized pharmaceutical formulations. Approved prescription products in Canada are subject to Health Canada oversight and specific regulatory standards.

However, HCG 10,000 IU, supplied in research-grade format, is categorized as an investigational laboratory compound. The research version is distinct from approved pharmaceutical preparations and is not represented as a therapeutic medication.

Scientific publications describing hCG include decades of endocrine research, reproductive physiology studies, and hormone receptor investigations. The laboratory-grade product aligns with this body of research literature but is provided exclusively for analytical and investigational purposes.

Regulatory Status in Canada

Pharmaceutical-grade hCG products are regulated by Health Canada when authorized for prescription use.

HCG 10,000 IU, supplied from Canada as a research compound, is classified separately as an investigational hormone for laboratory use only. It is not intended for human or veterinary administration and is not marketed as a prescription or over-the-counter medication.

Handling, storage, and research involving HC10,000 IU in Canada must comply with applicable federal and provincial regulations governing biological and chemical research materials. Laboratories and research institutions are responsible for ensuring regulatory compliance.

Molecular and Structural Notes

hCG is a heterodimeric glycoprotein hormone with a molecular weight of approximately 36–40 kDa, depending on glycosylation patterns. The alpha and beta subunits are non-covalently associated and extensively glycosylated, which contributes to stability and receptor-interaction properties.

The beta subunit confers biological specificity by enabling selective binding to the LHCGR receptor. Glycosylation patterns influence half-life and receptor affinity in experimental systems.

HCG 10,000 IU Canada is typically characterized in laboratory environments using bioassays and analytical methods to confirm identity, activity units, and purity before distribution.

The lyophilized format supports stability during storage when maintained under appropriate laboratory conditions.

Frequently Asked Questions

What is HCG 10,000 IU used for in research in Canada?
HCG 10,000 IU Canada is studied in laboratory settings to investigate luteinizing hormone receptor signalling and reproductive endocrinology pathways.

Is HCG 10,000 IU Canada-approvedfor therapeutic use?
The research-grade format is not authorized for therapeutic or consumer use. Approved pharmaceutical versions are regulated separately by Health Canada.

What type of hormone is hCG?
It is a glycoprotein hormone composed of alpha and beta subunits that binds to the luteinizing hormone receptor.

Does HCG 10,000iu Canada contain additives?
Unless specified in the batch documentation, the vial contains the purified lyophilized hormone preparation.

Can HCG 10,000 IU from Canada be used outside research facilities?
No. It is supplied strictly for controlled laboratory and analytical research purposes.

Educational Disclaimer

HCG 10,000iu Canada is an investigational research hormone supplied solely for laboratory and analytical use. It is not approved by Health Canada as a consumer product when provided in research-grade format.

The information presented on this page is educational in nature and based on publicly available scientific literature describing endocrine research contexts. No medical, diagnostic, or therapeutic claims are made.

Study and handling of HCG 10,000 IU in Canada should occur only within properly equipped research facilities and in accordance with applicable Canadian regulations and institutional guidelines.